is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Dear friends and colleagues,
Since its creation three decades ago, the EUROGIN congress has gained a strong reputation as one of the leading international conferences on HPV infection and associated cancers. The meeting offers a forum for high-level scientific exchange involving multiple disciplines, with the aim to translate research into clinical practice. Thanks to the top-ranking program committee the congress program offers up-to-date scientific information on the full range of HPV-related diseases.
For non-vaccinated populations, early detection and HPV based screening remains to be the key challenge.
The perspective of eliminating HPV infection and related cancers continues to be a major goal. HPV immunization on a large scale opens a priceless opportunity to reduce the burden of cervical, ano-genital and oral cancer all over the world. The journey started some time ago, but the destination has now come into sight: elimination of HPV related cancer.
As usual, the EUROGIN congress will offer a variety of educational opportunities for attendees: training courses, specialized workshops, scientific sessions, clinical sessions, free communications and poster presentations.
On behalf of the EUROGIN Organizing Committee, I am pleased to welcome you to EUROGIN.